Skip to content

Outcomes in Emergency Laparotomies During COVID-19 Pandemic

Emergency Laparotomies and Outcomes During the COVID-19 Pandemic - a Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04419571
Enrollment
94
Registered
2020-06-05
Start date
2020-03-23
Completion date
2020-06-16
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Emergency General Surgery

Brief summary

NLR has previously been observed to correlate with complications in upper GI (1) and colorectal (2) surgery. The investigators sought to assess if a similar correlation can be identified in emergency general surgical patients and if the presence of suspected or confirmed COVID-19 may impact on this. Given the heterogeneity of emergency general surgery the investigators therefore plan to perform a retrospective review of patients having emergency laparotomies only at a single NHS site during COVID-19 pandemic. Assessment of outcomes and Neutrophil:lymphocyte ratio as a predictor of outcomes will be completed. Outcomes will be completed in line with the recent COVIDSurg study criteria (3). The primary outcome is 30-day mortality. Secondary outcomes are 7-day mortality, re-operation, length of stay, post-operative respiratory failure, post-operative ARDS (Acute Respiratory Distress Syndrome), post-operative sepsis and ITU (Intensive Therapy Unit)/HDU (High Dependency Unit) admission.

Interventions

All adult patients undergoing emergency laparotomy

Sponsors

Barking, Havering and Redbridge University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing emergency laparotomy (change made due to heterogeneity of emergency general surgery)

Exclusion criteria

* Inherited or acquired immunodeficiency (which may directly skew NLR)

Design outcomes

Primary

MeasureTime frameDescription
30-day mortality30 daysMortality

Secondary

MeasureTime frameDescription
Length of stay30 daysInpatient stay during index admission
Post-operative respiratory failure30 daysPresence of respiratory failure in the post-operative period as defined in the clinical notes or discharge summaries
Post-operative ARDS30 daysARDS diagnosed radiologically
Post-operative sepsis30 daysPresence of sepsis in the post-operative period as defined in the clinical notes or discharge summaries
ITU/HDU admission30 daysITU/HDU admission post-operatively
7-day mortality7 daysMortality
Number of participants returning to theatre30 daysRe-operation

Other

MeasureTime frameDescription
Post-operative platelet countsFirst 3 post-operative daysAbsolute platelet counts recorded daily in the peri-operative period
Post-operative coagulopathyFirst 3 post-operative daysDefined as the presence of increased PT (prothrombin time) OR APTT (activated partial thromboplastin time) OR TT (thrombin time) OR fibrinogen above 1.5X the upper limit of normal. Coagulation will either be defined as normal or abnormal for each patient if one or more of these derangement are identified.
Other complications30 daysOther documented post-operative complications
Peri-operative NLRFirst 3 post-operative daysNeutrophil:Lymphocyte Ratio will be recorded daily in the peri-operative period

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026